TIMI Risk Score for Unstable Angina / NSTEMI
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۰ — حداکثر ۵ • واحد: count
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Low-Intermediate Risk2–2
- Intermediate Risk3–3
- Intermediate-High Risk4–4
The TIMI Risk Score for Unstable Angina / NSTEMI calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Estimates 30-day risk of death, myocardial infarction, or urgent revascularization in patients with unstable angina or non-ST-elevation MI. Helps triage to early invasive vs. conservative strategy.
Clinical Indication
The TIMI Risk Score for Unstable Angina / NSTEMI is indicated for bedside clinical practice to support Estimates 30-day risk of death, myocardial infarction, or urgent revascularization in patients with unstable angina or non-ST-elevation MI. Helps triage to early invasive vs. conservative strategy.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Derived before high-sensitivity troponin era; biomarker criterion applies to any elevated cardiac biomarker per local assay..
TIMI = age>=65 + risk_factors>=3 + known_CAD + ASA_7d + severe_angina + ST_deviation + biomarkers (1 point each)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient's age in years(years) |
| cad_risk_factor_count | integer | Yes | Number of CAD risk factors present (family history of CAD, hypertension, hypercholesterolemia, diabetes, current smoking). Counts toward the '>=3 risk factors' criterion.(count) |
| known_cad | boolean | Yes | Known coronary artery disease (documented stenosis >= 50%) |
| aspirin_last_7_days | boolean | Yes | Aspirin use in the past 7 days |
| severe_angina_24h | boolean | Yes | Severe angina: >= 2 anginal events in the prior 24 hours |
| st_deviation | boolean | Yes | ST-segment deviation >= 0.5 mm on presenting ECG |
| positive_biomarkers | boolean | Yes | Elevated cardiac biomarkers (troponin or CK-MB) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | 30-day risk of death/MI/urgent revascularization: 4.7% |
| 2–2 | Low-Intermediate Risk | 30-day risk of death/MI/urgent revascularization: 8.3% |
| 3–3 | Intermediate Risk | 30-day risk of death/MI/urgent revascularization: 13.2% |
| 4–4 | Intermediate-High Risk | 30-day risk of death/MI/urgent revascularization: 19.9% |
| 5–5 | High Risk | 30-day risk of death/MI/urgent revascularization: 26.2% |
| 6–7 | Very High Risk | 30-day risk of death/MI/urgent revascularization: 40.9% |
Evidence-Based References (EBM)
- Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835-842.